US Patent Issued to YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, UNIVERSITY OF RIJEKA FACULTY OF MEDICINE on Feb. 10 for "Antibodies specific to human Nectin-2" (Croatian, Israeli Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,727, issued on Feb. 10, was assigned to YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (Jerusalem) and UNIVERSITY OF RIJEKA FACULTY OF MEDICINE (Rijeka, Croatia).

"Antibodies specific to human Nectin-2" was invented by Ofer Mandelboim (Shoham, Israel), Pinchas Tsukerman (Jerusalem), Stipan Jonjic (Rijeka, Croatia), Tihana Lenac Rovis (Kastav, Croatia) and Paola Kucan Brlic (Rijeka, Croatia).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides monoclonal antibodies that recognize human Nectin-2 (Nectin-2, Poliovirus Receptor-Related Protein-2, Poliovirus Receptor-Like 2, CDI12, or PRR-2, is a s...